Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.489
Delayed Data
As of Apr 27
 -0.032 / -6.14%
Today’s Change
0.26
Today|||52-Week Range
1.51
-23.29%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Goldberg Michael M
President & Chief Executive Officer
Sale1/17/20175,411,850$0.01$54.1K-19.85%
Cope Frederick O
Chief Scientific Officer & Senior Vice President
Gift2/06/201788,378$0.52$46.0K-5.94%
Regan William J
Chief Compliance Officer & Senior Vice President
Gift2/06/201779,155$0.52$41.2K-5.94%
Klima Thomas J
Chief Commercial Officer & Senior Vice President
Gift2/06/201750,885$0.52$26.5K-5.94%
Goldberg Michael M
Director
Gift7/06/201643,580$0.50$21.8K-2.20%
Greene Mark I
Director
Gift1/10/201716,406$0.64$10.5K-23.44%
Greene Mark I
Director
Gift10/17/201611,413$0.87$9.9K-43.51%
Rice Michael /rdd/
Director
Gift6/14/201628,000$0.00$0.00-22.61%